|
Status |
Public on Mar 22, 2020 |
Title |
RNA-seq analysis of dolastatin 15 treatment in HCT116 cells |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
Dolastatin 15 is a known tubulin binding agent and shows remarkable differential cytotoxicity against a panel of colorectal HCT116 isogenic cells. The compound causes anti-vascularization effect in human endothelial cells (HUVEC) in a dose dependent manner. Antiangiogenic effect was further validated in a zebrafish genetic model with activated HIF
|
|
|
Overall design |
Examination of Dolastatin 15 effect on HCT116 cells relative to solvent controls using two different concentrations of 20 nM and 100 nM at 16 and 24 hour time points
|
|
|
Contributor(s) |
Luesch H, Ratnayake R |
Citation(s) |
32237262 |
Submission date |
Mar 23, 2019 |
Last update date |
Jun 24, 2020 |
Contact name |
Tongjun Gu |
E-mail(s) |
tgu@ufl.edu
|
Organization name |
The University of Florida
|
Department |
ICBR
|
Street address |
2033 Mowry Road
|
City |
Gainesville |
State/province |
FL |
ZIP/Postal code |
32610 |
Country |
USA |
|
|
Platforms (1) |
GPL21290 |
Illumina HiSeq 3000 (Homo sapiens) |
|
Samples (12)
|
GSM3684373 |
Dolastatin 15; 20 nM treatment at 16H sample 1 |
GSM3684374 |
Dolastatin 15; 20 nM treatment at 16H sample 2 |
GSM3684375 |
Dolastatin 15; 100 nM treatment at 16H sample 1 |
GSM3684376 |
Dolastatin 15; 100 nM treatment at 16H sample 2 |
GSM3684377 |
Dolastatin 15; solvent control for 16H sample 1 |
GSM3684378 |
Dolastatin 15; solvent control for 16H sample 2 |
GSM3684379 |
Dolastatin 15; 20 nM treatment at 24H sample 1 |
GSM3684380 |
Dolastatin 15; 20 nM treatment at 24H sample 2 |
GSM3684381 |
Dolastatin 15; 100 nM treatment at 24H sample 1 |
GSM3684382 |
Dolastatin 15; 100 nM treatment at 24H sample 2 |
GSM3684383 |
Dolastatin 15; solvent control for 24H sample 1 |
GSM3684384 |
Dolastatin 15; solvent control for 24H sample 2 |
|
Relations |
BioProject |
PRJNA528759 |
SRA |
SRP189242 |